BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12005126)

  • 1. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure: the Wittenoom data.
    Rogers A; Major G
    Ann Occup Hyg; 2002 Jan; 46(1):127-8; author reply 128-9. PubMed ID: 12005126
    [No Abstract]   [Full Text] [Related]  

  • 2. Exposures estimates of the Wittenoom mining workforce and town residents - Implications associated with risk estimation for persons exposed to asbestiform riebeckite.
    Rogers AJ
    Toxicol Appl Pharmacol; 2018 Dec; 361():168-170. PubMed ID: 30563645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia.
    Reid A; Heyworth J; de Klerk NH; Musk B
    Int J Cancer; 2008 May; 122(10):2337-44. PubMed ID: 18098288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational and environmental mesotheliomas due to crocidolite mining activities in Wittenoom, Western Australia.
    Rogers A; Nevill M
    Scand J Work Environ Health; 1995 Aug; 21(4):259-64. PubMed ID: 8552999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the risk of lung cancer in relation to exposure to asbestos and of taconite miners.
    Berry G; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S218-22. PubMed ID: 17998152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Browne K
    Ann Occup Hyg; 2001 Jun; 45(4):327-9; author reply 336-8. PubMed ID: 11414249
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
    Nicholson WJ; Raffn E
    Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of lung cancer and mesothelioma in people living near asbestos-related factories in Taiwan.
    Chang HY; Chen CR; Wang JD
    Arch Environ Health; 1999; 54(3):194-201. PubMed ID: 10444041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma vitamin concentrations and incidence of mesothelioma and lung cancer in individuals exposed to crocidolite at Wittenoom, Western Australia.
    Alfonso HS; Fritschi L; de Klerk NH; Ambrosini GL; Beilby J; Olsen N; Musk AW
    Eur J Cancer Prev; 2006 Aug; 15(4):290-4. PubMed ID: 16835500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mesothelioma in Pilbara Aborigines.
    Musk AW; de Klerk NH; Eccles JL; Hansen J; Shilkin KB
    Aust J Public Health; 1995 Oct; 19(5):520-2. PubMed ID: 8713204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare occupation causing mesothelioma: mechanisms and differential etiology.
    Mastrangelo G; Fadda E; Comiati V; Dell'Aquila M; Zamprogno E; Fedeli U; Bellini E
    Med Lav; 2014 Jul; 105(5):337-45. PubMed ID: 25134629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wittenoom legacy.
    Musk AWB; Reid A; Olsen N; Hobbs M; Armstrong B; Franklin P; Hui J; Layman L; Merler E; Brims F; Alfonso H; Shilkin K; Sodhi-Berry N; de Klerk N
    Int J Epidemiol; 2020 Apr; 49(2):467-476. PubMed ID: 31670764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia.
    Reid A; Berry G; Heyworth J; de Klerk NH; Musk AW
    Occup Environ Med; 2009 Mar; 66(3):169-74. PubMed ID: 18805882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysotile and crocidolite asbestos in Israel: uses, exposures and risks.
    Richter ED; Berdugo M; Laster R; Westin JB; Fischbein A
    Med Lav; 1995; 86(5):449-56. PubMed ID: 8684295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia.
    Alfonso HS; Reid A; de Klerk NH; Olsen N; Mina R; Ambrosini GL; Beilby J; Berry G; Musk BA
    Eur J Cancer Prev; 2010 Sep; 19(5):355-9. PubMed ID: 20571403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asbestos and cancer: An overview of current trends in Europe.
    Albin M; Magnani C; Krstev S; Rapiti E; Shefer I
    Environ Health Perspect; 1999 May; 107 Suppl 2(Suppl 2):289-98. PubMed ID: 10350513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of malignant mesothelioma in Australia.
    Musk AW; de Klerk NH
    Lung Cancer; 2004 Aug; 45 Suppl 1():S21-3. PubMed ID: 15261428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Hodgson JT; Darnton A
    Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.